NASDAQ:PALI

Palisade Bio Stock Insider Trading

etoro logo Buy PALI
*Your capital is at risk
$1.93
+0.0700 (+3.76%)
At Close: Jun 03, 2026

Palisade Bio Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 99.67. In total, the insiders bought 43.73M and sold 12.76K PALI shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
99.67
Buy 43.73M shares
Sell 12.76K shares
84% Buy Activity
Weak Negative Correlation

No Significant Signals

No statistically significant buy or sell signals detected in recent insider data.

Historical Insider Trades

Date Type Person Role Amount
Jul 11, 2024
Buy
Common Stock Options
A-Award
Williams Donald Allen
Director
Director 2 100
Value: $9K
Jul 11, 2024
Buy
Common Stock Options
A-Award
Fischbein Margery B.
Director
Director 2 100
Value: $9K
Jul 11, 2024
Buy
Common Stock Options
A-Award
Wei Binxian
Director
Director 2 100
Value: $9K
Jun 11, 2024
Buy
Comon Stock, par value $0.01
M-Exempt
Wei Binxian
Director
Director 465
Value: $2K
Jun 11, 2024
Buy
Comon Stock, par value $0.01
M-Exempt
Williams Donald Allen
Director
Director 340
Value: $2K
Jun 11, 2024
Buy
Comon Stock, par value $0.01
M-Exempt
Williams Donald Allen
Director
Director 340
Value: $2K
Jun 11, 2024
Buy
Comon Stock, par value $0.01
M-Exempt
Wei Binxian
Director
Director 465
Value: $2K
May 28, 2024
Buy
Common Stock, par value $0.01
M-Exempt
Jones Mitchell Lawrence
Chief Medical Officer
Officer 1 555
Value: $0
May 28, 2024
Sell
Common Stock, par value $0.01
F-InKind
Jones Mitchell Lawrence
Chief Medical Officer
Officer 461
Value: $2K
May 28, 2024
Buy
Common Stock, par value $0.01
M-Exempt
Jones Mitchell Lawrence
Chief Medical Officer
Officer 2 735
Value: $0
May 28, 2024
Sell
Common Stock, par value $0.01
F-InKind
Jones Mitchell Lawrence
Chief Medical Officer
Officer 810
Value: $4K
May 28, 2024
Buy
Restricted Stock Units
M-Exempt
Jones Mitchell Lawrence
Chief Medical Officer
Officer 1 555
Value: $0
May 28, 2024
Buy
Common Stock, par value $0.01
M-Exempt
Finley John David
CEO, CFO, Director
CEO / President 2 111
Value: $0
May 28, 2024
Sell
Common Stock, par value $0.01
F-InKind
Finley John David
CEO, CFO, Director
CEO / President 607
Value: $3K
May 28, 2024
Buy
Common Stock, par value $0.01
M-Exempt
Finley John David
CEO, CFO, Director
CEO / President 3 335
Value: $0
May 28, 2024
Sell
Common Stock, par value $0.01
F-InKind
Finley John David
CEO, CFO, Director
CEO / President 959
Value: $5K
May 28, 2024
Buy
Common Stock, par value $0.01
M-Exempt
Finley John David
CEO, CFO, Director
CEO / President 1 622
Value: $0
May 28, 2024
Sell
Common Stock, par value $0.01
F-InKind
Finley John David
CEO, CFO, Director
CEO / President 467
Value: $2K
May 28, 2024
Buy
Restricted Stock Units
M-Exempt
Finley John David
CEO, CFO, Director
CEO / President 2 111
Value: $0
May 28, 2024
Buy
Restricted Stock Units
M-Exempt
Finley John David
CEO, CFO, Director
CEO / President 2 111
Value: $0
May 28, 2024
Sell
Common Stock, par value $0.01
F-InKind
Finley John David
CEO, CFO, Director
CEO / President 467
Value: $2K
May 28, 2024
Buy
Common Stock, par value $0.01
M-Exempt
Finley John David
CEO, CFO, Director
CEO / President 1 622
Value: $0
May 28, 2024
Sell
Common Stock, par value $0.01
F-InKind
Finley John David
CEO, CFO, Director
CEO / President 959
Value: $5K
May 28, 2024
Buy
Common Stock, par value $0.01
M-Exempt
Finley John David
CEO, CFO, Director
CEO / President 3 335
Value: $0
May 28, 2024
Sell
Common Stock, par value $0.01
F-InKind
Finley John David
CEO, CFO, Director
CEO / President 607
Value: $3K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT PALISADE BIO, INC.
Palisade Bio
Palisade Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing oral therapies that target serious diseases associated with the breakdown of the mucosal barrier protecting the gastrointestinal tract. Its lead therapeutic candidate is LB1148, an oral liquid formulation of the digestive enzyme inhibitor that is intended to inhibit digestive enzyme activity and preserve gut integrity during int...
GOLDEN STAR
Ticker Change Signal Date
RUN
$12.83
18.86% May 06
GLBE
$31.61
5.35% May 05
SAP
$172.39
10.69% May 05
W
WCLD
$27.34
27.18% Apr 29
ADBE
$243.57
7.61% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE